Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cancer therapy using a combination of a Hsp90 inhibitory compounds and a EGFR inhibitor

Cancer therapy using a combination of a Hsp90 inhibitory compounds and a EGFR inhibitor

US Patent 9205086 · Granted Dec 8, 2015

Estimated economic value: $533,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Combination therapy of HSP90 inhibitors and PD-1 inhibitors for treating cancer2022
Combination therapies comprising targeted therapeutics2022
Combination therapy for treatment of ovarian cancer2021
Combination therapy of HSP90 inhibitors with platinum-containing agents2019
Cancer therapy using a combination of HSP90 inhibitors with topoisomerase I inhi2016
Combination therapy of HSP90 inhibitors with BRAF inhibitors2016
Triazole compounds that modulate Hsp90 activity2015
Imidazole compounds that modulate HSP90 activity2015
Method for treating proliferative disorders associated with mutations in c-Met2015
Method for treating non-Hodgkin's lymphoma2015
Triazone compounds that modulate HSP90 activity2015
Compounds for the treatment of proliferative disorders2015